Question 8374 — pharmacy and medicines

Summary

Mr. Jérôme Buisson draws the attention of the Minister of Labor, Health, Solidarity and Families to the economic and social consequences of the announced reduction in the ceiling for commercial discounts on generic and biosimilar medicines. These discounts, perfectly supervised and declared to the Economic Committee for Health Products (CEPS), represent an essential resource for the economic balance of pharmacies. They allow pharmacies to carry out their local mission while contributing significantly to controlling health insurance expenses. The decision to unilaterally reduce the rebate ceiling from 40% to a range of 20 to 25%, or even 15% for biosimilars, would constitute a major reversal in the policy of supporting generic medicines in France. Presented as a technical measure, it would have reality of serious consequences: pharmacy closures, workforce reductions, hiring freezes and lasting weakening of the pharmacy network, particularly in rural and peri-urban areas. According to the Union of Community Pharmacists' Unions (USPO), nearly 800 pharmacies could close in the short term if this reform were implemented. This situation would risk aggravating medical desertification, compromising access to local care and weaken already under-resourced areas. It would also call into question the effectiveness of the generic substitution system, hitherto recognized as an important lever for regulating health spending. Also, he asks if the Government intends to suspend this measure and quickly initiate consultation with representatives of the profession in order to preserve the economic balance of pharmacies, secure access to care in the territories and guarantee the sustainability of a local pharmacy model recognized by the French.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.